Evaluating the long‐term cost‐effectiveness of fixed‐ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real‐world clinical evidence

AIM: To evaluate the long‐term cost‐effectiveness of fixed‐ratio combination insulin degludec/liraglutide (IDegLira) versus comparator regimens for type 2 diabetes in Spain, based on real‐world evidence. MATERIALS AND METHODS: Clinical data were taken from the European Xultophy Treatment Retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Raya, Pedro Mezquita, Blasco, Francisco Javier Ampudia, Hunt, Barnaby, Martin, Virginia, Thorsted, Brian Larsen, Basse, Amaury, Price, Hermione
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594226/
https://www.ncbi.nlm.nih.gov/pubmed/30740861
http://dx.doi.org/10.1111/dom.13660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594226/
https://www.ncbi.nlm.nih.gov/pubmed/30740861
http://dx.doi.org/10.1111/dom.13660

Ejemplares similares